By From staff and wire reports Comments The University of Michigan says it is "carefully reviewing" the involvement of Sid Gilman, professor of neurology, in what prosecutors are calling one of the most lucrative insider trading schemes ever. Gilman's lawyer, Marc Mukasey, said his client is cooperating with the Securities and Exchange Commission and the U.S. Attorney's Office, and has entered into a non-prosecution agreement with federal prosecutors. According to charges filed in U.S. District Court in Manhattan, former hedge fund manager Mathew Martoma made an arrangement to obtain secret, advance results of tests on an experimental Alzheimer's drug that netted more than $276 million for...
↧